Claims
- 1. A method of potentiating the release and collection of cholesterol from inflammatory or atherosclerotic sites in vivo comprising: administering to a patient an effective amount of a composition comprising a compound selected from the group consisting of native serum amyloid A (SAA) and a ligand having SAA properties, wherein said SAA or ligand having SAA properties forms a complex with high density lipoprotein (HDL) and the HDL in said complex has increased affinity for macrophages relative to the affinity of free HDL, thereby potentiating release and collection of cholesterol from inflammatory or atherosclerotic sites.
- 2. The method of claim 1, wherein the compound is a ligand having SAA properties.
- 3. The method of claim 2, wherein the ligand is a non-amyloidogenic peptide derived from SAA.
- 4. The method of claim 1, wherein the native SAA is non-amyloidogenic.
- 5. The method of claim 1, wherein said HDL/SAA complex binds to a site on the macrophage separate and additional to the binding site for apo A-1 on the macrophage.
- 6. A method of reversing an atherosclerotic condition, comprising administering to a patient in need thereof an effective amount of a composition comprising a compound selected from the group consisting of native serum amyloid A (SAA) and a ligand having SAA properties, wherein said SAA or ligand having SAA properties forms a complex with high density lipoprotein (HDL) and the HDL in said complex has increased affinity for macrophages relative to the affinity of free HDL, thereby potentiating release and collection of cholesterol, such that an atherosclerotic condition is reversed.
- 7. The method of claim 6, wherein the compound is a ligand having SAA properties.
- 8. The method of claim 7, wherein the ligand is a non-amyloidogenic peptide derived from SAA.
- 9. The method of claim 6, wherein the native SAA is non-amyloidogenic.
- 10. The method of claim 6, wherein said HDL/SAA complex binds to a site on the macrophage separate and additional to the binding site for apo A-1 on the macrophage.
Parent Case Info
This application is a continuation-in-part of U.S. patent application Ser. No. 08/203,010, filed Feb. 28, 1994, abandoned, which is a continuation-in-part of U.S. patent application Ser. No. 07/890,936 filed May 29, 1992, now U.S. Pat. No. 5,318,958, issued Jun. 7, 1994. The contents of all of the aforementioned applications are expressly incorporated by reference. The contents of all of the referenced published patent applications and issued patents cited throughout this application are expressly incorporated by reference.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
5164295 |
Kisilevsky et al. |
Nov 1992 |
|
5216127 |
Hirai et al. |
Jun 1993 |
|
5276059 |
Caughey et al. |
Jan 1994 |
|
5318958 |
Kisilevsky |
Jun 1994 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
WO 93 24530 |
Dec 1993 |
WOX |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
203010 |
Feb 1994 |
|
Parent |
890936 |
May 1992 |
|